PROFILE

김영림 원장

Regulatory support for Orphan and essential drug
Of Korea Orphan and essential drug center (KOEDC)

The main role of Korea Orphan and essential drug center is stable supply of Orphan & Essential Drugs and ensure therapeutic opportunity for patients .
To ensure a stable supply of these drugs we monitor the situation of medical site. To expand treatment opportunities for patients with rare and incurable disease we will continue to make every efforts.

한국희귀필수의약품센터

EDUCATION

Ph.D. , Pharmacy, Seoul National University (1998.3~2003.8)
M.S, Pharmacy , Seoul National University (1988.3~1990.2)
B.S, Pharmacy, Seoul National University (1984.3~1988.2)

PROFESSIONAL EXPERIENCE

CEO of Korea Orphan and Essential Drug Center (KOEDC) (2025.4~)
Director General of Drug Evaluation Department of the Ministry of Food and Drug Safety (MFDS) (2023.7~2024.12)
Director (Gastroenterology, Antimicrobial Product, Oncology, Drug Standardization and Research Division, etc. of MFDS (2014.3~2023.6)
Scientific reviewer of several divisions of MFDS (1992.8~2014.2)

RESEARCH ACTIVITIES & OTHERS